Cathie Wood says these 3 health stocks will be the backbone of $1 trillion opportunity

Katherine Wood, CEO of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, October 18, 2021. Kyle Grelot | Bloomberg | Getty Images Gene-editing stocks may have been disappointing lately, but Cathy Wood still sees it as a great opportunity for long-term investors, highlighting three favorites. .

American Airlines, Gap, Moderna and more

An American Airlines plane lands at Ronald Reagan Washington National Airport on November 23, 2021 in Arlington, Virginia. Drew Angerer | Getty Images Check out which companies are making the headlines at midday Tuesday. American Airlines, Norwegian Cruise Line — Travel stocks fell, as investors continued to assess risks from the Covid-Omicron variant. American Airlines … Read more

5 things to know before the stock market opens Tuesday, Nov. 30

Here are the top news, trends and analysis that investors need to start their trading day 1. Dow futures fell 400 points as Omicron fears resurfaced A trader works on the floor of the New York Stock Exchange (NYSE) at the start of trading Monday after Friday’s sharp decline in global stocks due to fears … Read more

Jim Cramer says it’s too early to buy until we find out whether new variant is spreading in the U.S.

The sharp decline in stocks on Friday, driven by concerns about a new variant of Covid-19, is not a buying opportunity, according to CNBC’s Jim Cramer. “We will wake up next week and find one [case] In this country, and I wouldn’t recommend anyone to buy anything today until we make sure that doesn’t happen. … Read more

AstraZeneca antibody drug 83% effective at preventing Covid: Trial

AstraZeneca says its combination of an antibody, AZD7442, has yielded results considered positive against Covid-19 during a phase 3 clinical trial. Gerard Botino | SOPA photos | Light Rocket | Getty Images AstraZeneca antibody therapy has been shown to be highly effective in preventing Covid-19 in people who may not respond well to vaccines, according … Read more